ZA983250B - Polymer-platinum compounds. - Google Patents
Polymer-platinum compounds.Info
- Publication number
- ZA983250B ZA983250B ZA9803250A ZA983250A ZA983250B ZA 983250 B ZA983250 B ZA 983250B ZA 9803250 A ZA9803250 A ZA 9803250A ZA 983250 A ZA983250 A ZA 983250A ZA 983250 B ZA983250 B ZA 983250B
- Authority
- ZA
- South Africa
- Prior art keywords
- polymer
- platinum compounds
- platinum
- compound
- backbone
- Prior art date
Links
- 229940045985 antineoplastic platinum compound Drugs 0.000 title 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000015636 Oligopeptides Human genes 0.000 abstract 1
- 108010038807 Oligopeptides Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
- 150000003058 platinum compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Electroplating And Plating Baths Therefor (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4474397P | 1997-04-18 | 1997-04-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA983250B true ZA983250B (en) | 1998-10-18 |
Family
ID=21934085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9803250A ZA983250B (en) | 1997-04-18 | 1998-04-17 | Polymer-platinum compounds. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5965118A (xx) |
| EP (1) | EP1009439B1 (xx) |
| JP (2) | JP4536165B2 (xx) |
| AT (1) | ATE230613T1 (xx) |
| AU (1) | AU736297B2 (xx) |
| CA (1) | CA2286091C (xx) |
| DE (1) | DE69810636T2 (xx) |
| DK (1) | DK1009439T3 (xx) |
| ES (1) | ES2194312T3 (xx) |
| TW (1) | TW509573B (xx) |
| WO (1) | WO1998047537A1 (xx) |
| ZA (1) | ZA983250B (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2396702C (en) * | 2000-01-04 | 2010-03-23 | Access Pharmaceuticals, Inc. | N,o-amidomalonate platinum complexes |
| US7166733B2 (en) * | 2000-01-04 | 2007-01-23 | Access Pharmaceuticals, Inc. | O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes |
| AU2006222657B2 (en) * | 2000-01-04 | 2009-01-15 | Access Pharmaceuticals, Inc. | N,O-amidomalonate platinum complexes |
| WO2002020663A2 (en) | 2000-09-06 | 2002-03-14 | Ap Pharma, Inc. | Degradable polyacetal polymers |
| SG92833A1 (en) | 2001-03-27 | 2002-11-19 | Sumitomo Chemical Co | Polymeric light emitting substance and polymer light emitting device using the same |
| KR100484504B1 (ko) * | 2001-09-18 | 2005-04-20 | 학교법인 포항공과대학교 | 쿠커비투릴 유도체를 주인 분자로서 포함하고 있는 내포화합물 및 이를 포함한 약제학적 조성물 |
| US7754684B2 (en) * | 2003-06-11 | 2010-07-13 | Access Pharmaceuticals, Inc. | Macromolecular platinum chelates |
| CA2631704A1 (en) | 2005-12-05 | 2007-06-14 | Nitto Denko Corporation | Polyglutamate-amino acid conjugates and methods |
| US20080279782A1 (en) * | 2007-05-09 | 2008-11-13 | Nitto Denko Corporation | Polymers conjugated with platinum drugs |
| JP2012505228A (ja) * | 2008-10-07 | 2012-03-01 | レクサン ファーマシューティカルズ インコーポレイテッド | Ｈｐｍａ−ドセタキセルまたはゲムシタビンコンジュゲートおよびその使用 |
| BR112012008772A2 (pt) * | 2009-10-13 | 2017-06-20 | Rexahn Pharmaceuticals Inc | sistemas poliméricos para a liberação de agentes anti-câncer |
| EP2743273A1 (de) | 2012-12-12 | 2014-06-18 | Umicore AG & Co. KG | Verfahren zur Herstellung wasserhaltiger Zubereitungen von Komplexen der Platingruppenmetalle |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS173846B1 (xx) * | 1974-04-23 | 1977-03-31 | ||
| CS173849B1 (xx) * | 1974-04-25 | 1977-03-31 | ||
| IL73972A0 (en) * | 1984-12-31 | 1985-03-31 | Yeda Res & Dev | Agents based on platinum compounds |
| GB8500209D0 (en) * | 1985-01-04 | 1985-02-13 | Ceskoslovenska Akademie Ved | Synthetic polymeric drugs |
| IN165717B (xx) * | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
| US4931553A (en) * | 1988-05-11 | 1990-06-05 | Gill Devinder S | Platinum-polymer complexes and their use as antitumor agents |
| US5420105A (en) * | 1988-09-23 | 1995-05-30 | Gustavson; Linda M. | Polymeric carriers for non-covalent drug conjugation |
| GB9017024D0 (en) * | 1990-08-03 | 1990-09-19 | Erba Carlo Spa | New linker for bioactive agents |
| US5484584A (en) * | 1990-10-02 | 1996-01-16 | Board Of Regents, The University Of Texas System | Therapeutic and diagnostic use of modified polymeric microcapsules |
| GB9026491D0 (en) * | 1990-12-05 | 1991-01-23 | Erba Carlo Spa | Anthracycline-conjugates |
| GB9200247D0 (en) * | 1992-01-07 | 1992-02-26 | Erba Carlo Spa | Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
| GB9213077D0 (en) * | 1992-06-19 | 1992-08-05 | Erba Carlo Spa | Polymerbound taxol derivatives |
| GB2270920B (en) * | 1992-09-25 | 1997-04-02 | Univ Keele | Alginate-bioactive agent conjugates |
| KR0164460B1 (ko) * | 1995-10-02 | 1999-03-20 | 김은영 | 고분자 백금 착화합물, 그의 제조방법 및 그를 유효성분으로 하는 항암제 |
-
1998
- 1998-04-14 US US09/060,455 patent/US5965118A/en not_active Expired - Lifetime
- 1998-04-15 WO PCT/US1998/006770 patent/WO1998047537A1/en active IP Right Grant
- 1998-04-15 DK DK98918020T patent/DK1009439T3/da active
- 1998-04-15 CA CA2286091A patent/CA2286091C/en not_active Expired - Fee Related
- 1998-04-15 AU AU71026/98A patent/AU736297B2/en not_active Ceased
- 1998-04-15 ES ES98918020T patent/ES2194312T3/es not_active Expired - Lifetime
- 1998-04-15 AT AT98918020T patent/ATE230613T1/de active
- 1998-04-15 EP EP98918020A patent/EP1009439B1/en not_active Expired - Lifetime
- 1998-04-15 JP JP54608398A patent/JP4536165B2/ja not_active Expired - Fee Related
- 1998-04-15 DE DE69810636T patent/DE69810636T2/de not_active Expired - Lifetime
- 1998-04-17 ZA ZA9803250A patent/ZA983250B/xx unknown
- 1998-04-18 TW TW087105951A patent/TW509573B/zh not_active IP Right Cessation
-
2010
- 2010-02-04 JP JP2010023626A patent/JP2010132685A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE69810636T2 (de) | 2003-11-06 |
| DE69810636D1 (de) | 2003-02-13 |
| CA2286091C (en) | 2010-07-06 |
| EP1009439A1 (en) | 2000-06-21 |
| ATE230613T1 (de) | 2003-01-15 |
| WO1998047537A1 (en) | 1998-10-29 |
| TW509573B (en) | 2002-11-11 |
| JP4536165B2 (ja) | 2010-09-01 |
| CA2286091A1 (en) | 1998-10-29 |
| DK1009439T3 (da) | 2003-05-05 |
| EP1009439B1 (en) | 2003-01-08 |
| ES2194312T3 (es) | 2003-11-16 |
| JP2010132685A (ja) | 2010-06-17 |
| AU7102698A (en) | 1998-11-13 |
| US5965118A (en) | 1999-10-12 |
| JP2001524098A (ja) | 2001-11-27 |
| AU736297B2 (en) | 2001-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT927150E (pt) | Compostos de lipoxina e sua utilizacao no tratamento de doencas proliferativas celulares | |
| ZA200007040B (en) | Catalyst modifiers and their use in the polymerization of olefin(s). | |
| DE69623927D1 (de) | Russzusammensetzungen und verbesserte polymerzusammensetzungen | |
| HK1031884A1 (en) | Prostaglandin agonists and their use to treat bonedisorders. | |
| ZA983250B (en) | Polymer-platinum compounds. | |
| DE68900305D1 (de) | Kammerbuegel und baum fuer sattel. | |
| DE69518919T2 (de) | Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung | |
| HUP0004655A3 (en) | Modified alumoxane catalyst activator | |
| DE59611481D1 (en) | Chromatin-regulatorgene | |
| NL194084B (nl) | Roeten alsmede rubbersamenstellingen met dergelijke roeten. | |
| MX9707570A (es) | Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria. | |
| NZ333402A (en) | Derivatized rhodamine dye and its copolymers | |
| ID21529A (id) | Metode dan komposisi untuk pengobatan dan pencegahan tumor, gangguan yang berhubungan dengan tumor dan kakeksia | |
| NZ511020A (en) | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use | |
| PT1017408E (pt) | Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii | |
| IL127468A0 (en) | Substituted benzylidene formamides acetamides and propionamides | |
| BR9907025B1 (pt) | Polissacarídeos sintéticos e uso dos mesmos | |
| CA2290482A1 (en) | Fructan containing composition for the prevention and treatment of colon cancer | |
| DE58902899D1 (de) | 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer. | |
| DE69729768D1 (de) | Herzschrittmacher mit Bestimmung des anaeroben Schwellwertes | |
| GB2324091A (en) | Metalloproteinase inhibitors | |
| WO1998047496A3 (en) | Polymer-platinum compounds | |
| HK1015806A1 (en) | Treated carbonaceous compositions and improved polymer compositions | |
| HUT51657A (en) | Polymer compositions comprising waste rubber and/or waste leather as auxiliaries | |
| GB9626472D0 (en) | New use of comt inhibitors |